Inactive Instrument

Other languages MAXO CAP

Equities

Maxpro Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Apollomics, Inc. completed the acquisition of Maxpro Capital Acquisition Corp. from MP One Investment LLC and others in a reverse merger.	23-03-28
Apollomics Gets Orphan Drug Designation for Vebreltinib to Treat Lung Cancer	22-11-15
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02
Apollomics to be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition	22-09-14
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11
Maxpro Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16

No results for this search